首页 | 本学科首页   官方微博 | 高级检索  
检索        

异烟肼缓释胶囊的研制及药动学
引用本文:郭建平,徐辉.异烟肼缓释胶囊的研制及药动学[J].中国药学杂志,1998,33(2):95-98.
作者姓名:郭建平  徐辉
作者单位:天津 300020 中国人民解放军第272医院
摘    要: 目的:制备异烟肼缓释胶囊,评价人体内药动学、生物利用度及患者体内血药浓度。方法:乙基纤维素为载体,相分离 凝聚法制微囊,转篮法测释放特性;紫外光度法测10名志愿者单剂量po400mg异烟肼缓释胶囊与普通片后血药浓度,数据经MCP86药动学程序处理。结果:体外释药:普通片T50=0.032h;缓释胶囊:T50=1h,释药10h以上。普通片cmax=11.12μg·ml-1,tmax=1.41h,K:0.201h-1;36h血药浓度:0μg·ml-1。缓释胶囊:cmax=4.99μg·ml-1,tmax=1.80h,K=0.03·h-1,36h血药浓度:1.63μg·ml-1。配对与双侧检验结果表明:两者除tmax无显著性差异外,cmax及消除速率常数(k)均有显著性差异(P<0.01)。患者体内血药浓度:普通片与缓释胶囊分别为:1.5h时:(8.24±2.60)μg·ml-1,(3.69±0.51)μg·ml-1;36h:0μg·ml-1,2.09μg·ml-1。结论:该缓释胶囊处方合理、工艺简单,适用于工业化生产,可为结核患者临床防治提供一个新剂型。

关 键 词:异烟肼  微囊  缓释胶囊
收稿时间:1997-03-26;

Preparation and release and pharmacokinetics of sustained-release isoniazid
Guo Jianping,Xu Hui.Preparation and release and pharmacokinetics of sustained-release isoniazid[J].Chinese Pharmaceutical Journal,1998,33(2):95-98.
Authors:Guo Jianping  Xu Hui
Institution:(Guo JP),Xu Hui (Xu H
Abstract:To prepare and study the pharmacokinetics and release bioavailability in olunteers and concentrations in plasma in patients. METHODS: Ethylcellulose was used matrix in phase separation-coacervation for preparation of microencapsulation. The release experiments were performed in a rotating shaker. The isoniazid concentration in plasma was determined by spectrophotometrical method following a single oral dose of sustained-release cupsule and ordinary tablet respectively given to 10 volunteers in a open randomized cross-over test. MCP86 was used to process main pharmacokinetic parameters. RESULTS: The sustained-release of capsule and ordinary teblet in vitro, T50 was 1 h and 0.032 h respectively. The drug in sustained-release capsule was sustained release over 10 h. The main parameters in body: ordinary tablets: cmax=11.12 μgml-1, tmax=1.41 h, K=0.201 h-1; sustained release capsule: cmax=4.99 μgml-1, tmax=1.80 h, K=0.03 h-1. The concentration of blood at 36 h was (0±0)μgml-1 and 1.63 μgml-1 respectively. Except tmax, there was significant difference between the two fomulations (P<0.01). The concentration of blood in patient at 1.5 h and 36 h. ordinary tablet and sustained-release capsule respectively were (8.24±2.60)μgml-1, (0±0)μgml-1and (3.69±0.86)μgml-1, (2.09±0.56)μgml-1. CONCLUSION: The sustained-release capsule will play an important part in prevention and treatment of tuberculosis as the result of its reasonable formulation and simple technology.
Keywords:isoniazid  microcapsule  sustained-release capsule  pharmacokinetics
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国药学杂志》浏览原始摘要信息
点击此处可从《中国药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号